Abstract
Get full access to this article
View all access options for this article.
References
1.
Kieny
MP
Dovlo
D.
Beyond Ebola: a new agenda for resilient health systems . Lancet 2015 ; 385 : 91 –92 .
2.
Nam
SL
Blanchet
K.
We mustn’t forget other essential health services during the Ebola crisis . BMJ 2014 ; 349 : g6837 .
3.
Gostin
LO
Friedman
EA.
A retrospective and prospective analysis of the west African Ebola virus disease epidemic: robust national health systems at the foundation and an empowered WHO at the apex . Lancet 2015 ; 385 : 1902 –1909 .
4.
Chiappelli
F
Bakhordarian
A
Thames
AD
. Ebola: translational science considerations . J Transl Med 2015 ; 13 : 11 .
5.World Health Organization (WHO) . Background document: potential Ebola therapies and vaccines , http://www.who.int/csr/disease/ebola/ebola-new-interventions-02-sep-2014.pdf?ua=1 (2014 , accessed 30 October 2015 )
6.
Bishop
BM.
Potential and emerging treatment options for Ebola virus disease . Ann Pharmacother 2015 ; 49 : 196 –206 .
7.
Dye
JM
Herbert
AS
Kuehne
AI
. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease . Proc Natl Acad Sci USA 2012 ; 109 : 5034 –5039 .
8.
Bwaka
MA
Bonnet
MJ
Calain
P
. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients . J Infect Dis 1999 ; 179 (Suppl. ): S1 –S7 .
9.
Cohen
J.
Infectious Disease. Ebola vaccines racing forward at record pace . Science 2014 ; 345 : 1228 –1229 .
10.
Borio
L
Cox
E
Lurie
N.
Combating emerging threats—accelerating the availability of medical therapies . N Engl J Med 2015 ; 373 : 993 –995 .
11.World Health Organization (WHO) . Ethical considerations for use of unregistered interventions for Ebola viral disease (EVD) , 2014 , http://apps.who.int/iris/bitstream/10665/130997/1/WHO_HIS_KER_GHE_14.1_eng.pdf
12.World Health Organization (WHO) . Meeting summary of the WHO consultation on potential Ebola therapies and vaccines . Geneva , 4–5 September 2014 , http://apps.who.int/iris/bitstream/10665/136103/1/WHO_EVD_Meet_EMP_14.1_eng.pdf?ua=1 (2014 , accessed 11 November 2015 ).
13.World Health Organization (WHO) . Global health ethics—key issues , http://apps.who.int/iris/bitstream/10665/164576/1/9789240694033_eng.pdf (2015 , accessed 11 November 2015 ).
14.
Mupapa
K
Mukundu
W
Bwaka
MA
. Ebola hemorrhagic fever and pregnancy . J Infect Dis 1999 ; 179 (Suppl. 1 ): S11 –S12 .
15.
Kitching
A
Walsh
A
Morgan
D.
Ebola in pregnancy: risk and clinical outcomes . BJOG 2015 ; 122 : 287 .
16.
Lang
T.
Ebola: embed research in outbreak response . Nature 2015 ; 524 : 29 –31 .
17.
Bah
EI
Lamah
MC
Fletcher
T
. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea . N Engl J Med 2015 ; 372 : 40 –47 .
18.
Henao-Restrepo
AM
Longini
IM
Egger
M
. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial . Lancet 2015 ; 386 : 857 –866 .
19.World Health Organization (WHO) . Ethical issues related to study design for trials on therapeutics for Ebola Virus Disease . In: WHO ethics working group meeting (Summary of discussion) , 20–21 October , http://apps.who.int/iris/bitstream/10665/137509/1/WHO_HIS_KER_GHE_14.2_eng.pdf?ua=1 (2014 , accessed 30 October 2015 ).
20.World Health Organization (WHO) . Ethical considerations in developing a public health response to pandemic influenza: technical report , http://apps.who.int/iris/bitstream/10665/70006/1/WHO_CDS_EPR_GIP_2007.2_eng.pdf?ua=1&ua=1 (2007 , accessed 30 October 2015 ).
21.World Health Organization (WHO) . Guidance on ethics and equitable access to HIV treatment and care , http://www.who.int/ethics/publications/9241592583/en/ (2004 , accessed 30 October 2015 ).